# Oramed Pharmaceuticals Inc. (ORMP) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$15M |
| 2023 | -$16M |
| 2022 | -$41M |
| 2021 | -$24M |
| 2020 | -$12M |
| 2019 | -$15M |
| 2018 | -$14M |
| 2017 | -$11M |
| 2016 | -$10M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-03-31 | -$5M |
| 2023-06-30 | -$4M |
| 2023-03-31 | -$5M |
| 2022-09-30 | -$8M |
| 2022-06-30 | -$11M |
| 2022-03-31 | -$11M |
| 2021-12-31 | -$12M |
| 2021-11-30 | -$8M |
| 2021-09-30 | -$7M |
| 2021-06-30 | -$4M |
| 2021-05-31 | -$6M |
| 2021-03-31 | -$7M |
| 2021-02-28 | -$5M |
| 2020-12-31 | -$8M |
| 2020-11-30 | -$6M |
| 2020-05-31 | -$2M |
| 2020-02-29 | -$4M |
| 2019-11-30 | -$2M |
| 2019-05-31 | -$4M |
| 2019-02-28 | -$4M |
| 2018-11-30 | -$5M |
| 2018-05-31 | -$5M |
| 2018-02-28 | -$3M |
| 2017-11-30 | -$3M |

Source: [CompaniesByCap](https://companiesbycap.com/company/ORMP/operating-income)